Systemic oxidative stress associates with the development of post-COVID-19 syndrome in non-hospitalized individuals
Non-hospitalized individuals with COVID-19 show evidence of systemic oxidative stress, which is longitudinally associated with the development of PCS. Our results provide a rationale for future studies to further investigate the value of R-SH as a monitoring biomarker and a potential therapeutic target in the development of PCS.
Authors
- Karin I. Wold (ORCID: https://orcid.org/0000-0002-8750-7474)
- Harry van Goor (ORCID: https://orcid.org/0000-0002-6670-1577)
- Arno R. Bourgonje (ORCID: https://orcid.org/0000-0001-5754-3821)
- Bernardina T.F. van der Gun (ORCID: https://orcid.org/0000-0001-5207-6814)
- A.C.M. Veloo (ORCID: https://orcid.org/0000-0002-0095-8740)
- Wilfred F.A. den Dunnen (ORCID: https://orcid.org/0000-0002-4168-1207)
- Martin H. de Borst (ORCID: https://orcid.org/0000-0002-4127-8733)
- Adriana Tami (ORCID: https://orcid.org/0000-0002-1918-9144)
- Jan‐Luuk Hillebrands (ORCID: https://orcid.org/0000-0003-3135-3274)
- María Fernanda González (ORCID: https://orcid.org/0000-0001-7435-6497)
- Larissa E. Vlaming-van Eijk
- Marian Bulthuis
Institutions
- University Medical Center Groningen (NL)
- University of Groningen (NL)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Redox Biology
- Published
- 2024-08-19
- DOI
- https://doi.org/10.1016/j.redox.2024.103310
- Citations
- 7
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 2.58
Funders
- ZonMw
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- HORIZON EUROPE Framework Programme
- Horizon 2020
- Janssen Pharmaceuticals